title: British Association of Dermatologists' guidelines for the safe and effective prescribing of azathioprine 2011.
authors.affiliation: Department of Dermatology, Royal Victoria Infirmary, Queen Victoria Road, Newcastle upon Tyne NE1 4LP, UK. s.j.meggitt@ncl.ac.uk
authors.forename: S J
authors.initials: SJ
authors.lastname: Meggitt
authors.forename: A V
authors.initials: AV
authors.lastname: Anstey
authors.forename: M F
authors.initials: MF
authors.lastname: Mohd Mustapa
authors.forename: N J
authors.initials: NJ
authors.lastname: Reynolds
authors.forename: S
authors.initials: S
authors.lastname: Wakelin
mesh_terms: D000014:Abnormalities, Drug-Induced / Q000209:etiology; D000328:Adult; D000368:Aged; D001379:Azathioprine / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D001855:Bone Marrow Diseases / Q000139:chemically induced; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology / Q000628:therapy; D002648:Child; D003362:Cost-Benefit Analysis; D004334:Drug Administration Schedule; D017277:Drug Approval; D016527:Drug Costs; D004342:Drug Hypersensitivity / Q000209:etiology; D004347:Drug Interactions; D005260:Female; D005820:Genetic Testing; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D007239:Infections / Q000139:chemically induced; D007674:Kidney Diseases / Q000150:complications; D007774:Lactation; D008297:Male; D008780:Methyltransferases / Q000378:metabolism; D009325:Nausea / Q000139:chemically induced / Q000628:therapy; D009369:Neoplasms / Q000139:chemically induced; D056687:Off-Label Use; D010353:Patient Education as Topic; D011247:Pregnancy; D012307:Risk Factors; D012871:Skin Diseases / Q000188:drug therapy*; D013866:Thioguanine / Q000378:metabolism; D014777:Virus Diseases / Q000150:complications
chemical_list: D007166:Immunosuppressive Agents; D008780:Methyltransferases; C022745:thiopurine methyltransferase; D013866:Thioguanine; D001379:Azathioprine